- GE HEALTHCARE
- MEDTRONIC PLC
- KONINKLIJKE PHILIPS N.V.
- ABBOTT LABORATORIES
- NIHON KOHDEN CORPORATION
- MASIMO CORPORATION
- OMRON CORPORATION
- EDWARDS LIFESCIENCES CORPORATION
- HILL-ROM HOLDINGS, INC.
- DRÄGERWERK AG & CO. KGAA
- NATUS MEDICAL
- GETINGE AB
- COMPUMEDICS LIMITED
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
- NONIN
- BIOTRONIK
- BOSTON SCIENTIFIC CORPORATION
(Note: The list of the major players will be updated with the latest market scenario and trends)
Recent developments by key players in Patient Monitoring Devices Market:
In January 2022- In order to promote health improvements for individuals with chronic diseases, MDLIVE launched patient health monitoring. For those who have chronic health issues, including diabetes, heart disease, or high blood pressure, this digital-first program seeks to enhance health outcomes.
Due to an increase in sedentary lifestyles, which include poor nutrition, inactivity, and high sugar consumption, the market is predicted to rise significantly over the course of the projected period. Obesity and diabetes are just two of the chronic diseases that are associated with these lifestyles. The prevalence of chronic illnesses, including diabetes, renal disease, and stroke, is expected to rise, raising the demand for patient monitoring equipment. Also, due to escalating healthcare expenditures, particularly in hospital settings, the focus has recently switched to alternate treatment modalities, including home healthcare. In addition, the frequency of hospital readmissions has dramatically decreased since the introduction of remote and home monitoring technology. The need for effective home-use gadgets, including fetal and neonatal monitors, ECG recorders, temperature monitors, pulse oximeters, and event monitors, is rising. Technological advancements that lead to the creation of home-use gadgets are expected to create opportunities for key market players to expand their portfolios and yield revenue in this target market. Moreover, the market is also growing because of the increased adoption of wearable and remote patient monitoring technology. Biosensors, wearable patient monitoring devices, and smart implants are used in various applications, such as temperature monitoring, continuous glucose monitoring, pulse oximetry, and blood pressure monitoring. The Internet of Things (IoT) and sensors is the most recent iteration of wearable technology. Wearable biosensors monitor vital signals such as electrocardiography, blood pressure, blood sugar, and weight and send them to a central server over the link. AI in healthcare devices is making diagnosis easier for both patients and clinicians. Individuals' growing knowledge of their health has resulted in a contemporary trend. However, the possibility of system failures, on the other hand, is a key factor that can limit market expansion. The high prices linked with this technology are another key issue that could restrict the market's expansion potential. Due to these technologies' high development costs and failure rates, investors are discouraged from investing in them, which restricts the emergence of novel inventions. Ineffective reimbursement procedures and a lack of legislative rules are two more factors that might impede market revenue growth.